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The bacterial AAA +  enhancer-binding proteins (EBPs) HrpR and Hrps (HrpRs) of Pseudomonas 
syringae (Ps) activate σ54-dependent transcription at the hrpL promoter; triggering type-three 
secretion system-mediated pathogenicity. In contrast with singly acting EBPs, the evolution 
of the strictly co-operative HrpRs pair raises questions of potential benefits and mechanistic 
differences this transcription control system offers. Here, we show distinct properties of HrpR 
and Hrps variants, indicating functional specialization of these non-redundant, tandemly 
arranged paralogues. Activities of HrpR, Hrps and their control proteins HrpV and HrpG from 
Ps pv. tomato DC3000 in vitro establish that HrpRs forms a transcriptionally active hetero-
hexamer, that there is a direct negative regulatory role for HrpV through specific binding to 
Hrps and that HrpG suppresses HrpV. The distinct HrpR and Hrps functionalities suggest how 
partial paralogue degeneration has potentially led to a novel control mechanism for EBPs and 
indicate subunit-specific roles for EBPs in σ54-RnA polymerase activation. 
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Many bacterial pathogens use a type-three secretion system (T3SS) to deliver proteins into host cells (reviewed in ref. 1). hrp and hrc genes establish the regulatory and structural 
functions associated with the T3SS from the group I-type hrp/hrc 
cluster of Pseudomonas, Erwinia and former Erwinia phytopathogens 
(for example, Pectobacterium and Dickeya spp.)2. hop genes encode 
secreted pathogenicity effectors and the majority of hop genes and 
hrp/hrc cluster genes are regulated by the extracytoplasmic func-
tion σ-factor HrpL, which is regulated by the σ54-dependent hrpL 
promoter3,4. Regulation of σ54-RNA polymerase (σ54-RNAP) activ-
ity is achieved by the action of specific enhancer-binding proteins 
(EBPs)5,6. In phytopathogenic fluorescent Pseudomonas spp., other 
than Pseudomonas syringae (Ps), and in the phytopathogenic species 
in the Enterobacteriaceae, a single EBP, HrpS, activates transcription 
from the hrpL promoter7. In Ps, hrpL expression is activated by a 
co-dependent pair of EBPs; HrpR and HrpS8.
EBPs are molecular machines belonging to the AAA +  (ATPases 
associated with various cellular activities) superfamily9 of P-loop 
ATPases. They remodel σ54-RNAP at its promoter sites and, via a 
carboxy (C)-terminal HTH domain, bind promoter upstream acti-
vator sites (UASs). The ATPase activity of EBPs relies on the forma-
tion of hexameric ring-like assemblies6. This feature is commonly 
exploited by cis-acting regulatory domains to control the activity 
of EBPs by either impairing (as in DctD and NtrC1) or promoting 
(as in NtrC) hexamer assembly10. The EBPs HrpR and HrpS, similar 
to the well-studied EBP PspF, lack cis-acting regulatory domains 
and comprise only the AAA +  and HTH domains. PspF activity 
is directly negatively regulated by an additional protein, PspA11. 
HrpV is thought to fulfill a similar regulatory role in the HrpRS 
and probably HrpS systems12. Repression of HrpV is proposed 
to be released through the action of HrpG13.
The vast majority of bacterial AAA +  proteins studied so far 
form homo-hexameric AAA +  rings, whereas their eukaryotic 
isoenzymes often function as heteromeric assemblies. For instance, 
the mini chromosomal maintenance (MCM) complex, a processive 
replicative helicase, functions as a typical AAA +  homo-hexameric 
ring in archaea14, but the eukaryotic isoenzyme (MCM: Mcm2-7p) 
is heteromeric15. The hrpRS genes are transcribed as an operon, pro-
posed to form a functional heteromeric HrpRS AAA +  complex of 
unknown quaternary structure8. The advantage that such a dual EBP 
system confers on T3SS-mediated pathogenicity in Ps is unclear.
Multiple sensory systems as well as abiotic and biotic inputs are 
used in regulating expression from group I hrp regulons. Among 
these sensory systems are Lon, GacA, HrpXY, rsmA/B, HrpRS, HrpV, 
HrpG and quorum-sensing components7,8,12,13,16–19. Here, we study 
the HrpRS, HrpV and HrpG components of Ps DC3000 and report: 
direct evidence for a single mixed composition functional hexameric 
HrpRS complex; that HrpR and HrpS each contact σ54; that HrpR 
and HrpS make unequal contributions to the ATP-dependent and 
HrpV-controlled functioning of the hetero-hexamer and; specific 
binding of HrpV to HrpS is used in a novel inhibition and regulation 
mechanism that is sensitive to HrpG action. These findings provide 
detailed insights into the molecular evolution of an EBP system that 
distinguishes Ps from non-syringae plant pathogens.
Results
Gene duplication leading to HrpRS is distinctive for Ps. In Ps  
(including DC3000), hrpR and hrpS are arranged in tandem 
(hrpRS), transcribed as a single operon8 and exhibit high sequence 
similarity, suggesting that they have evolved from a single ancestral 
gene duplication event. A search for the highest similar sequences 
for group I-type pathogenicity islands (PAIs) identified ten non-
redundant hrpRS tandem arrangements (in Ps pathovars) and ten 
single-hrpS sequences (in Erwinia-type pathovars as well as the hrpS 
homologue rspR from P. fluorescens). All 20 inspected PAIs also 
harbour the regulatory genes hrpV and hrpG, including P. mendocina 
(a P. aeruginosa-related human pathogen20), suggesting that the 
appearance of hrpRS is more recent than that of the presumed hrpS 
regulatory genes (hrpV and hrpG). Although regulatory roles for 
HrpV and HrpG remain to be established for non-syringae strains 
they have been clearly annotated as hrpV and hrpG across genera 
and the synteny of the intra-operon loci are strictly conserved. A 
phylogenetic tree based on protein sequences derived from the 
30 EBPs obtained is shown in Supplementary Figure S1. Where 
present HrpR and HrpS have 55–65% sequence identity and 70–
79% sequence similarity to each other (Supplementary Table S1—
compared with other well-studied bacterial EBPs, such as ZraR, 
PspF, NtrC1, which have 38–41% identity; Supplementary Table 
S2). Strikingly, hrpRS was found in all Ps pathovars, making the dual 
hrpRS EBP system a distinguishing feature in the hrp/hrc gene cluster 
of group I PAI in Ps pathovars. Further, no polymorphism (hrpRS 
or hrpS) has been reported for Ps. We did not find polymorphism 
among identified PAI (including among redundant sequences); 
strongly suggesting that hrpRS in Ps provides a selective advantage 
compared with singly acting hrpS. The exact branch pattern 
symmetry between the HrpSRS and HrpR groups (Supplementary 
Fig. S1) suggests that following gene duplication, hrpR and hrpS 
may not have diverged freely as is commonly assumed in gene 
duplication due to functional redundancy21,22. Inspection of the 
HrpR and HrpS sequences of Ps DC3000 and their predicted 
structures indicate no obvious basis of their co-dependency. They 
show clear congruence with other EBPs (Supplementary Fig. S2), 
in that the seven conserved regions identified for all EBPs and the 
conserved AAA +  motifs are present (Fig. 1a)5.
Specialization of HrpR and HrpS mechanism and regulation. 
Initially, we expressed wild-type (WT) HrpR, HrpS, HrpV and 
HrpG in Escherichia coli, and assayed activities using a PhrpL::lacZ 
reporter integrated into the chromosome (see Methods and Sup-
plementary Table S3). As shown in Figure 1b, co-expressed HrpR 
and HrpS (expressed simultaneously from different plasmid con-
structs) or HrpRS (co-expressed as a single operon), but not HrpR 
or HrpS alone (expressed singly), resulted in elevated β-galactosi-
dase activity—in line with the strict requirement for both HrpR and 
HrpS to activate hrpL transcription. Western blotting confirmed 
that both HrpR and HrpS were stably expressed, excluding gross 
protein instability at the level of proteolysis as a basis of their co-
dependence in vivo (Supplementary Fig. S3), although HrpR–HrpS 
assembly defects cannot be excluded. Co-expression of HrpRS 
and HrpV resulted in reduced transcription activation (Fig. 1b, 
HrpRS + HrpV), demonstrating that HrpV negatively controls the 
functionality of HrpRS in the absence of other Ps-specific factors 
in vivo. Notably, expression of HrpG partly released the negative 
effect of HrpV on HrpRS activity.
Biochemical studies with AAA +  proteins, including EBPs, sug-
gest that non-synchronized ATP hydrolysis occurs between indi-
vidual subunits of homomeric complexes23,24. To address this notion 
more directly, we introduced equivalent single amino-acid sub-
stitutions into EBP functionally important motifs in either HrpR 
or HrpS (Fig. 1a) to delineate the specific roles of conserved EBP 
sequences within the context of heteromeric HrpRS6. We assayed 
the effect of amino-acid substitutions, on in vivo PhrpL transcription 
activation (Fig. 1c,d). As shown in Figure 1c,d, the β-galactosidase 
activities of HrpR and HrpS variant forms demonstrated that the 
integrity of the Walker A (P-loop) motif was required for in vivo 
promoter activation. Substitutions in the HrpS Walker B motif 
(E108, Fig. 1d), expected to be essential for ATP hydrolysis, and the 
sensor II residue R226, retain significant residual activity (51 Miller 
Units (MU) and 32 MU, respectively). In contrast (Fig. 1c) the cor-
responding substitutions in HrpR showed no detectable activity 
(E110 and R228; 2 MU and 1 MU, respectively; where the back-
ground level is 2 MU and 100% activity corresponds to 350 MU). 
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Given that Walker B residues and the sensor II ‘R’ residue are critical 
for ATP hydrolysis and EBP functionality (in terms of the ability 
to stimulate open complex (OC) formation)25,26, these data suggest 
mechanistic subunit specialization in the ATP hydrolysis-associated 
functionalities of HrpR and HrpS.
EBPs contact σ54 via the consensus GAFTGA motif27. Such inter-
actions depend on the nucleotide-bound state28–30 and rely on the 
integrity of the ‘F’ and ‘T’ residues27,31. In HrpR, this sequence is pre-
dominantly GAFTGV and in HrpS is always GAYTGA (including 
in singly acting HrpS; Supplementary Fig. S2). Deviation from the 
consensus GAFTGA motif in HrpR and HrpS may reflect subunit 
specialization in contacting σ54. Substituting Y for F in HrpS, resulted 
in a 50% increase in activity compared with WT HrpRS (Fig. 1e), 
indicating that HrpS can interact with σ54, yet appears to limit the 
activity of HrpRS. As substituting Y for F in HrpS did not over-
come the requirement for HrpR, we infer that the non-consensus 
residue Y85 is not the basis of HrpRS co-dependency. Substitution 
of the near invariant T residue (present in  > 97% of identified EBPs; 
a key σ54-contacting residue, yet does not affect the self-assembly or 
ATPase activities of PspF27) for A in either HrpR or HrpS led to a 
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Figure 1 | In vivo transcription and protein–protein interactions of Hrp proteins. (a) Domain organization of EBPs showing the seven conserved regions 
(C1–C7) and their associated functions. HrpR and Hrps key motif sequences are given with the sites of amino-acid substitutions (used in c, d, e below) 
indicated (black typeface numbering refers to amino-acid position in either HrpR or Hrps). (b) In vivo transcription activation activities measured from the 
chromosomal promoter hrpL::lacZ reporter construct—given as a percentage of WT co-expressed (single operon) HrpRs activity (where WT = 100%)—of 
singly expressed HrpR or Hrps, and co-expressed HrpR + Hrps (HrpR + s) (from different plasmids). HrpV expression abolishes HrpRs in vivo activity 
(HrpRs + HrpV), which is partly relieved when co-expressing HrpG (HrpRs + HrpV + HrpG). (c) As in b transcription activation by HrpRs, where HrpR 
carries mutations as indicated. (d) As in b transcription activation by HrpRs, where Hrps carries mutations as indicated. (e) As in b transcription  
activation by HrpRs, where Hrps carries the gain of function mutation Y85F. (f) Bar graph depicting results of the BACTH protein–protein binding 
interactions between HrpR (black), Hrps (light grey), Hrps1 − 275 (dark grey), HrpV (white), HrpG (grey) inferred by β-galactosidase production and 
displayed in miller units (mu)32. B/ground represents the background level of β-galactosidase activity detected for the negative control (30 mu—obtained 
with the two-hybrid vectors in the absence of protein fusions). (g) scheme of the expression construct for the BACTH three component system. (h) Bar 
graph depicting the binding interactions between T25-fused proteins HrpR, Hrps, HrpV and HrpG with T18C-fused Hrps in the presence of co-expressed 
HrpV in a three-component two-hybrid system35 inferred by β-galactosidase production and displayed in miller units. In b–e, all assays were minimally 
performed in triplicate and standard errors of the mean are shown. Protein expression was verified by western blotting (see supplementary Fig. s3).
ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1177
nATuRE CommunICATIons | 2:177 | DoI: 10.1038/ncomms1177 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
loss of transcription activation; demonstrating that both the HrpR 
and HrpS σ54-contacting ‘GAFTGA’ sequences are strictly required.
Clearly HrpR and HrpS have each evolved mechanistic speciali-
zation, providing direct evidence for subunit-specific roles of this 
novel EBP system in activating σ54-RNAP.
Interactions between the Hrp proteins. We analysed the protein–
protein interactions that occur within the HrpRS, HrpV and HrpG 
regulatory complexes in vivo using a bacterial two-hybrid system, 
BACTH32. We verified that all two-hybrid fusion proteins were 
similarly expressed (Supplementary Fig. S3)—thereby establishing 
that failure to detect an interaction was not simply due to unstable 
Hrp-fusion proteins. Consistent with earlier findings, HrpS self-
associates and interacts with both HrpR and HrpV, but not HrpG 
(Fig. 1f). HrpV also interacts with HrpG. HrpR did not detectibly 
interact with itself, HrpV or HrpG (Fig. 1f and refs 8, 13). Glutaral-
dehyde crosslinking with co-purified HrpRS and purified HrpV, and 
followed by western blotting using antibodies specific to HrpR, 
HrpS (His-tag) and HrpV established direct binding of HrpV to 
HrpS can occur independently of additional factors (Supplemen-
tary Fig. 3). To distinguish which HrpS domain contributed to the 
different binding interactions, we created a C-terminal HTH trun-
cation variant, HrpS1 − 275 (the HrpS AAA +  domain), and analysed 
interactions with full-length (FL) HrpS, HrpR, HrpV and HrpG. In 
contrast to HrpS, HrpS1 − 275 showed no detectable interactions with 
itself or HrpR—suggesting oligomerization determinants in HrpS 
reside in the HTH domain, consistent with dimerization function-
alities in NtrC33. Importantly, interaction activities are retained 
between HrpS1 − 275 and HrpV, suggesting that HrpV acts directly by 
binding the HrpS AAA +  domain.
Regulation of EBPs is commonly achieved by altering higher-
order oligomer formation (and hence ATPase activity10,34). We there-
fore tested whether HrpV affected subunit-binding interactions 
within the HrpRS complex by co-expressing native HrpV together 
with the BACTH protein fusions to form a three-component system 
(Fig. 1g)35. Our results demonstrate that expression of native HrpV 
greatly increased HrpS self-association and moderately increased 
HrpR–HrpS interactions (Fig. 1h), suggesting that HrpV binding 
to HrpS somewhat alters subunit–subunit interactions within the 
self-assembled HrpRS complex. Western blotting confirmed that 
the levels of HrpR and HrpS production were similar in the pres-
ence of the extra copy of HrpV (Supplementary Fig. S3). Given the 
absence of detectable interactions between HrpS and HrpG (even in 
the presence of HrpV), we infer that HrpV may not bind HrpS 
and HrpG simultaneously and that HrpG relieves HrpV inhibition 
by precluding HrpV–HrpS interactions.
HrpV and HrpG act antagonistically to control HrpRS activity. 
The ways in which heteromeric EBPs may differ from singly act-
ing EBPs are not known. We therefore investigated features in the 
HrpRS system that are common to EBPs: the presence of and co-
operative binding to UAS DNA; a facilitating role of integration host 
factor (IHF) to increase productive interactions between the EBP 
and σ54-RNAP closed complex; a strict nucleotide-dependency dur-
ing transcription activation, and the regulation of EBPs by modulat-
ing the oligomeric state and/or DNA-binding activity.
To gain insights into the HrpRS system, we purified FL HrpR, 
HrpS, HrpRS (co-expressed), IHF, HrpV and HrpG. In vitro stud-
ies of many other EBPs36,37 have been performed using isolated 
EBP domains, because of the difficulties associated with limited 
solubility of FL EBPs38–41. HrpR and HrpS when expressed and puri-
fied separately resulted in substantially lower protein yields than 
co-expressed HrpRS, suggesting that HrpR/HrpS mutually stabi-
lize a soluble heteromeric conformation (in line with oligomeriza-
tion determinants residing within the AAA +  and HTH domains; 
Fig. 1c,d,f). Further, attempts to co-purify HrpRS complexes 
harbouring Walker B alanine substitutions in either HrpR or HrpS 
resulted in very low protein yields, probably due to a failure to form 
stable HrpRS complexes as observed with the equivalent substitutions 
in PspF42.
The activity of the purified HrpRS complex was measured using 
an in vitro single-round transcription assay from the supercoiled 
hrpL promoter. As shown in Figure 2a, FL transcript formation 
required σ54-RNAP, dATP and HrpRS. Purified IHF greatly stim-
ulated the amount of FL transcript obtained in vitro. Notably, the 
absence of FL transcripts with HrpR alone, HrpS alone or separately 
purified and mixed in vitro HrpR and HrpS (HrpR + HrpS), sug-
gests that in vivo self-assembly of the HrpRS complex is important 
for forming the active HrpRS complex (Fig. 2b). HrpRS activated 
transcription when RNAP was reconstituted with either Klebsiella 
pneumoniae (Kp) or Ps σ54 (Fig. 2c), indicating that HrpRS can 
function independently of Ps-specific σ54.
Purified HrpV inhibited HrpRS-dependent activation of 
σ54-RNAP transcription (Fig. 2d) at a 1:1 ratio (HrpV:HrpRS), 
independent of the constant concentrations of DNA, σ54-RNAP 
and IHF. We infer that HrpV directly acts to diminish productive 
interactions HrpRS makes with the closed promoter complex. To 
establish that HrpV specifically inhibits the action of the HrpRS 
complex, we tested whether HrpV could inhibit transcription acti-
vation by an alternate EBP (the AAA +  domain of PspF), using the 
σ54-dependent Sinorhizobium meliloti nifH test promoter, which 
lacks the HrpRS UASs present in the hrpL promoter. As shown in 
Figure 2e, although PspF and HrpRS are both able to activate σ54-
dependent transcription at the nifH promoter, only the activity of 
HrpRS is inhibited by HrpV. Clearly, the action of HrpV is specific 
in targeting HrpRS and does not require the UAS sequences (in 
line with the observation that HrpV does not reduce HrpRS UAS 
binding; (Fig. 2f and see below). Moreover, the addition of HrpV or 
HrpRS–V did not destabilize preformed PspF-dependent σ54-RNAP 
OCs, suggesting HrpV acts before OC formation (Fig. 2g; compare 
OC to OC + HrpRS–V and OC + HrpV). HrpV did not inhibit the 
ATPase activity of HrpRS (where the ATPase turnover rate per min 
for 1 µM HrpRS was: 0.180 ± 0.02 (minus HrpV), 0.192 ± 0.02 (plus 
1 µM HrpV) and 0.183 ± 0.02 (plus 10 µM HrpV) and the ATPase 
buffer did not prevent HrpS from interacting with HrpV, Fig. 2h). 
Overall, these data establish that HrpV acts via a mechanism spe-
cific to the HrpS subunit of the HrpRS complex, not previously 
described for other EBPs.
Further, HrpG when added to the HrpRS–V regulatory com-
plex (Fig. 2e), relieved some of the inhibitory action of HrpV (as 
observed in vivo) but had no stimulatory effect on transcription 
activation by PspF. These results establish that HrpG functions as a 
specific suppressor for HrpV activity and that HrpG and HrpV can 
function independently of any Ps-specific factors.
HrpRS co-dependency is hrpL promoter independent. We estab-
lished that the hrpL promoter (PhrpL) contains a functional UAS 
between positions  − 147 to  − 36 relative to the transcription start-
site (Fig. 3a,b), to which purified HrpR, HrpS and HrpRS bind in 
electrophoretic mobility shift assays (Fig. 3c,d). Consistent with the 
in vitro observations, in which addition of IHF greatly stimulated 
transcription (Fig. 2a), hrpL-dependent in vivo transcription in an 
IHF deletion strain was marginal (Fig. 3b). The specific IHF-bind-
ing site is present in the promoter probe (Fig. 3e), probably pro-
moting productive interactions between HrpRS and σ54-RNAP, as 
evidenced by the increased transcription activity in vivo (Fig. 3b) 
and in vitro (Fig. 2a). Compared with either HrpR alone or HrpS 
alone or when HrpR and HrpS were mixed together (denoted as 
HrpR + HrpS, Fig. 3c), co-purified HrpRS bound the UAS DNA 
with greater affinity (Fig. 3d), indicating co-operative binding to the 
PhrpL. Lack of increased UAS binding in the presence of pre-mixed, 
separately purified HrpR and HrpS, probably reflects incompetent 
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subunit assembly (in line with the in vitro transcription assays; 
Fig. 2b). These features of the hrpL promoter are in good agreement 
with other EBP interactions at σ54-dependent promoters in terms of 
co-operative binding to the UAS and exclude promoter architecture 
as the major basis of HrpRS co-dependency43.
HrpR and HrpS are not equivalent for nucleotide binding. Identi-
cal subunits in EBPs and other AAA +  proteins make delineation of 
mechanistic roles of individual subunits experimentally challeng-
ing44. To directly probe any non-equivalence of HrpR and HrpS 
subunits (as suggested by the mutagenesis studies; Fig. 1c,d), in the 
context of the purified functional HrpRS complex, we tested nucle-
otide binding with non-equilibrium covalent ultraviolet crosslink-
ing39,45 of [α-32P]ATP using PspF as a control. Recall that the highly 
conserved Walker A motif (GXXXXGK[T/S]), especially, the ‘K’ 
residue, is strictly required for nucleotide binding in AAA +  pro-
teins46, including EBPs39,47. As shown in Figure 4, HrpR and HrpS 
were separated by SDS–PAGE and the relative protein concentra-
tions evaluated by SYPRO ruby protein stain fluorescence (Sy). 
The relative amount of [α-32P]ATP crosslinked protein species was 
determined by PhosphorImager analysis. Side-by-side compari-
son of the relative [α-32P]ATP/fluorescence intensities (Fig. 4a) of 
the HrpR and HrpS bands indicate that [α-32P]ATP preferentially 
crosslinks to HrpR and at a level comparable to that of the struc-
turally and functionally characterized EBP PspF39 (Fig. 4b). Spe-
cific binding of [α-32P]ATP to HrpR is further demonstrated by the 
competitive binding of non-radiolabelled ADP, ATP and ATPγS 
(Fig. 4a). Differential nucleotide binding to particular subunits of 
the strictly co-dependent HrpRS system provides direct evidence 
for non-equivalent nucleotide-dependent roles for individual 
subunits in a functional EBP complex.
The HrpRS hetero-hexamer is the most active assembly. Gel- 
filtration of co-purified HrpRS (Fig. 5a) resolved at least two distinct 
species with molecular weights (MWs) corresponding to 212 kDa 
(apparent 6.1 mer) and 52 kDa (apparent 1.4 mer)—where the 
MW of HrpR is 34.9 kDa and HrpSHis is 34.5 kDa. The lower MW 
peak does not permit assignment of subunit composition(s) and 
may comprise a mixture of monomers and dimers. SDS–PAGE 
analysis (Fig. 5b) of the fractions demonstrates that HrpR and 
HrpS are present in both peaks. Interestingly, we note that the rela-
tive intensities of HrpR and HrpS differ significantly between the 
hexameric (hex) species (where HrpS predominates over HrpR) 
and monomer/dimer species (where HrpR predominates over 
HrpS). The relative HrpR/HrpS fluorescence intensities are consist-
ently scored as ~0.5 in fractions 5–8; suggesting a fixed HrpR/HrpS 
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stoichiometry in the hexameric fractions—although precise deter-
mination of the stoichiometry of this complex was not possible 
using this approach. Re-produced retention volumes (Fig. 5a, hex 
re-run) and concentration-independent ATPase turnover rates of 
the re-chromatographed or diluted hexameric HrpRS fraction (Fig. 
5c; fraction 7) indicate that the HrpRS hexamer is stable minimally 
over the purification and assay time course and at the concentrations 
used. Further evidence that HrpRS forms a mixed subunit hexam-
eric assembly was obtained using glutaraldehyde protein–protein 
crosslinking (Fig. 5d); where a hexameric crosslinked species that 
reacted to HrpR- (α-HrpR) and His-tag-antibodies (to detect HrpS; 
α-His) was detected.
Taking the relative total HrpRS protein concentrations of the 
individual gel filtered fractions into account, we determined the 
ATPase turnover rates of all fractions and found that the hexameric 
species was the most active (Fig. 5c). The HrpRS concentration in 
the hexameric fraction was too low to detect transcription in vitro  
(Fig. 5e). However, the gel-filtration purified HrpRS monomer/dimer 
fraction (fraction 10) was unable to detectibly activate σ54-RNAP, 
whereas the original loading sample (diluted to the same concentra-
tion as the gel-filtered HrpRS monomer/dimer fraction) supported 
transcription (Fig. 5e). We infer that the hexameric HrpRS assembly 
is the active form. These results suggest that a defined subunit com-
position of a HrpRS hexamer confers the highest transcription and 
ATPase activities.
Discussion
Gene duplication events followed by recombination and/or diver-
sification are thought to be the major driving force for evolution-
ary innovation48, but knowledge of the molecular mechanisms that 
underpin selection of duplicated genes is fragmented49. Despite 
considerable hrp/hrc gene similarities, the evolution of hrpRS 
through duplication is the most distinguishing feature of Ps PAIs 
(pathovars include tomato, tagetis (marigold), phaseolicola (bean) 
and oryzae (rice)). We now provide insights into the mechanistic 
diversification of HrpR and HrpS and their regulation by HrpV 
and HrpG. Uncommon for gene duplication events, duplication 
of an EBP ancestor has not resulted in functional independence, 
but has locked the diverging HrpR and HrpS subunits into strict 
co-dependence, possibly explaining their high sequence conser-
vation. HrpR appears to have become specialized in nucleotide-
dependent functionalities, whereas HrpS retained a HrpV-dependent 
regulatory function. Our results suggest no obvious mechanistic 
advantage of the HrpRS system in activating σ54-dependent tran-
scription when compared with singly acting EBPs, rather there may 
be regulatory advantages conferred by having only HrpS targeted 
by HrpV. In line with this, deletion of Lon protease correlates with 
HrpR (and not HrpS) accumulation in vivo—although it is unclear 
whether Lon degrades HrpR directly16,17,19. The divergent roles of 
HrpR and HrpS described here provide one example of regulatory 
specialization of one subunit of a strictly co-dependent system, thus 
illustrating how partial sub-functionalization (for example, reduced 
ATP binding by HrpS, inability of HrpR to interact with HrpV) 
could occur in combination with neo-functionalization (for exam-
ple, acquisition of a novel interaction between HrpR and Lon)19.
Purified HrpRS is competent to activate transcription, is nega-
tively regulated in trans by HrpV and this repression is released by 
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HrpG, establishing that the HrpRSVG system is sufficient for regu-
lated expression at the hrpL promoter in vitro. Activity of HrpRS in 
E. coli, with K. pneumoniae σ54 and S. meliloti promoter sequences 
indicated that the HrpRS system does not require Ps-specific factors 
to function. Amino-acid residues essential for nucleotide binding 
and hydrolysis are important for HrpRS activity in vivo, particularly 
in the case of HrpR. However, as the ATPase activity and oligomeric 
states have not been tested in vivo, we cannot exclude that assembly 
defects account for lack of activity. Significantly, mutations in cata-
lytic residues in HrpS (D107, E108 and R226), thought essential for 
activity in EBPs, did not abolish transcription activity in HrpRS39,50. 
The requirement for both HrpR and HrpS σ54-binding motifs sug-
gests an active, and not merely structural role, for each protein 
in the HrpRS complex. Binding of HrpV to HrpS and not HrpR 
implies a subunit-specific negative control mechanism not previ-
ously described for other EBPs. HrpV can completely repress HrpRS 
activity, but does not directly inhibit each subunit of the functional 
hexamer; potentially acting allosterically and/or sterically blocking 
access to the RNA polymerase closed complex. Allostery could be 
achieved through topological effects on the HrpRS hexameric ring 
in line with HrpV-mediated changes in the interactions between 
HrpR and HrpS (suggested in the BACTH assays; Fig. 1h). The 
action of HrpV is distinct in that it does not alter the ATPase or 
DNA-binding activities of HrpRS. In contrast, NifL diminishes the 
ATPase and DNA-binding properties of the EBP NifA, and PspA 
inhibits the ATPase activity of PspF11,51.
Heteromeric AAA +  proteins have been reported as stacked 
homo-hexameric rings (for example, the bacterial proteases ClpA/
ClpX52 and human ATPases Tip48/Tip49 (ref. 53)), or as a single 
hetero-hexameric ring (in the case of eukaryotic MCM; Mcm2-7p), 
or as homo-multimers (as in prokaryotic and archeal MCM)14,15. 
Notably, the six distinct subunits of Mcm2-7p demonstrate clear 
mechanistic specialization in binding and hydrolyzing ATP15. We 
now show that HrpRS forms a hetero-hexameric structure. The dis-
tinct ATP-binding activities and functional roles of HrpR and HrpS 
provide direct evidence that individual subunits in EBPs may not 
be functionally equivalent, and that asymmetric functioning may 
underpin their action.
Methods
Bacterial strains and plasmids. FL hrpR, hrpS, hrpRS (as a single operon), hrpV 
and hrpG genes were amplified by PCR from Ps DC3000 genomic DNA (see Sup-
plementary Table S3 for all strains and plasmids used in this study). The bacterial 
two-hybrid (BACTH) fusion proteins were amplified with flanking 5′-XbaI and 
3′-KpnI restriction sites and cloned into the corresponding pUT18C and pKT25 
vectors. To construct the pUT18C-hrpS/hrpV plasmid (co-expressing T18-HrpS 
and WT HrpV) a DNA fragment encompassing the Shine–Dalgarno sequence  
and hrpV was PCR amplified to include flanking 5′-KpnI and 3′-EcoRI restriction 
sites and cloned into pUT18C-hrpS (see Fig. 1g). Mutations in hrpR or hrpS were  
introduced using the QuikChange method (Agilent technologies) as instructed. All 
recombinant plasmids were verified by sequencing.
The PhrpL transcriptional lacZ-reporter fusion (hrpLlacZ) was constructed 
by amplifying 0.6 kbp of the hrpL promoter region as an EcoRI-BamHI fragment 
from Ps DC3000 genomic DNA and subcloning into pRS415 (ref. 54)—creating 
pAVM415. The single-copy chromosomal fusion of hrpLlacZ was constructed 
as described55. Briefly, phage λBDC531 (imm21) was grown in a strain carrying 
pAVM415. The resulting λ phages were used to generate lysogens in SA1943 and 
screened for a Gal −  phenotype on MacConkey galactose agar plates supplemented 
with ampicillin (100 µg ml − 1). P1 phage was grown on the lysogens and the result-
ant lysates used to transduce the recipient strain DY226, which was screened for 
ampicillin resistant transductants at 42 °C. The constructed strain carrying the 
PhrpL::lacZ fusion was then screened for the Bio +  phenotype and the presence of 
prophage (sensitivity to λ phages). Finally, the PhrpL::lacZ fusion was moved by P1 
transduction (by selecting for ampicillin resistance) into strain MC4100, generating 
strain MJ2806.
In vivo -galactosidase assays. β-Galactosidase assays56 and BACTH assays were 
performed as described32. Briefly, proteins were fused to either the T18 or T25 
fragments of adenylate cyclase (plasmids pT18C and pT25, respectively) and co-
transformed into BTH101 cells. Interaction efficiencies were quantified by measur-
ing the β-galactosidase activity of the cultures following induction (for 2 h at 25 °C) 
with 0.5 mM isopropyl-β-d-thiogalactoside at mid-log phase56.
Protein purification. Proteins used in this study, HrpR, HrpS, HrpRS, HrpV, 
HrpG, IHF, E. coli PspF, Kp σ54 and Ps σ54, were over-expressed (using 0.5 mM 
isopropyl-β-d-thiogalactoside) in E. coli and purified essentially as described25.  
Briefly, cell pellets were re-suspended in buffer ANI (50 mM sodium phosphate 
buffer pH 7.0, 500 mM NaCl, 0.1 mM EDTA, 5% glycerol) supplemented with  
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Figure 5 | A stable HrpRS hetero-hexameric species appears to be 
the active form. (a) Analytical HPLC gel-filtration vertically offset 
chromatograms of co-purified HrpRs (top); re-chromatographed fraction 
 7 (Hex re-run) and fraction 10 (monomer/dimer (m/d) re-run). The  
apparent monomer/dimer (m/d), hexamer (hex), void volume (void) 
retentions are indicated. molecular mass standards (right) and their 
retention volumes used to calculate the apparent mW of the peaks.  
(b) sDs–PAGE of the sYPRo-stained fractions collected during gel-filtration 
in a. The relative fluorescence intensity ratios of HrpR/Hrps are plotted in 
the line graph (superimposed on the gel-filtration profile of HrpRs; grey).  
(c) Bar chart illustrating the ATPase turnover rates (min − 1) of the fractions in 
b (superimposed on the gel-filtration profile of HrpRs; grey). Concentration-
independent ATP turnover rates in a twofold dilution series of fraction 7 
(hex) compared with dilutions of fraction 10 (m/d). (d) Glutaraldehyde 
crosslinked HrpR, HrpRs and PspFR168A complexes were separated by sDs–
PAGE and analysed by western blotting using antibodies specific to HrpR 
(α-HrpR), Hrps (α-His) or PspF (α-PspF). migration mobilities of several 
higher-order oligomeric species (labelled dimer, tetramer and hexamer) are 
indicated. (e) In vitro transcription assay (as in Fig. 2a, where FL represents 
the full-length transcript of ~470 nt) of the monomer/dimer fraction 10 from 
a (m/d) at 0.2 µm compared with an equimolar concentration of HrpRs  
(0.2 µm), before gel filtration. In c, all assays were minimally performed  
in triplicates and standard errors of the mean are shown.
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protease inhibitor cocktail (Roche), disrupted by sonication and the resultant 
soluble fraction purified by metal affinity chromatography using a linear gradient 
of 0–1 M imidazole (in buffer ANI). The desired protein fractions were dialysed 
overnight against storage buffer (20 mM Tris pH 8.0, 50 mM NaCl, 0.1 mM EDTA 
and 5% glycerol). HrpG was purified from the insoluble cell fraction by urea-dena-
turation, which involved resuspending the cell pellet in buffer ANI containing 8 M 
urea. The rest of the Ni-affinity purification protocol remained the same. IHF was 
purified exactly as described57.
FL transcription assays. FL transcription assays were performed in either TTH 
(10 mM Tris-HCl, pH 7.5, 70 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, 1 mM 
EDTA, 12.5% glycerol and 0.1% w/v Triton X-100) or STA (25 mM Tris-acetate, pH 
8.0, 8 mM Mg-acetate, 10 mM KCl and 3.5% w/v PEG 6000) buffer (for the hrpL 
or nifH promoters respectively) in a 10 µl volume containing 100 nM σ54-RNAP 
(reconstituted at a 1:5 ratio RNAP:σ54), 20 nM supercoiled promoter DNA and 
where stated 4 mM dATP, 20 nM IHF and equimolar (to [HrpRS]) concentrations 
of HrpV and/or HrpG (unless stated). OC formation was initiated by addition of 
0.8 µM HrpR, HrpS or HrpRS (for the hrpL promoter, unless otherwise stated) 
or 2 µM HrpRS or PspF (for the nifH promoter, unless otherwise stated) and 
incubated at room temperature (RT) for 1 h. Concentration stated refers to the 
monomer concentration for HrpR, HrpS or PspF and the dimer concentration for 
HrpRS. Transcription was initiated with a mix containing 100 µg ml − 1 heparin, 
0.1 mM ATP, CTP, GTP, 0.05 mM UTP and 3 µCi of [α-32P]UTP and incubated for 
10–20 min at RT (hrpL) or 37 °C (nifH). Reactions were quenched with loading dye 
and analysed on 6% denaturing gels. Gels were dried and transcripts visualized and 
quantified using a Fuji FLA-5000 PhosphorImager.
In vitro glutaraldehyde crosslinking. Assays were conducted in a total reaction 
volume of 10 µl, in HGNED buffer (25 mM HEPES, pH 8.0, 1 mM dithiothreitol, 
100 mM NaCl, 0.2 mM EDTA, 0.05% (v/v) NP-40 and 10% (v/v) glycerol) contain-
ing 2.5 µM of the specified proteins. Samples were treated with glutaraldehyde (at a 
final concentration 0.1%) and incubated at RT for 10 min. Reactions were stopped 
by addition of 2 µl stop solution (200 mM Tris-HCl pH 7.5, 200 mM glycine). 
Crosslinked protein complexes were separated by 10% SDS–PAGE and analysed by 
western blotting (see below).
Western blotting. Crosslinked complexes were separated by SDS–PAGE and 
transferred onto polyvinylidene difluoride membrane using a semidry transblot 
system (Bio-Rad). Western blotting was performed as described11 using antibod-
ies specific to either Ps HrpR (α-HrpR; 1:10,000), Ps HrpS (α-HrpS; 1:10,000), Ps 
HrpV (α-HrpV; 1:5,000), E. coli PspF (α-PspF; 1:4,000), His-tag (to detect HrpS; 
α-His; 1:1,000; Promega) or the BACTH fusion construct pKT25 (α-pKT25; 
1:500). Proteins were detected using the ECL plus Western Blotting Detection Kit 
(GE Healthcare) as instructed.
In vitro native gel mobility shift assays. Assays were performed in TTH (see 
above) buffer in a 20 µl total reaction volume at RT. Briefly, 10 nM of a 32P-end 
labelled DNA fragment (comprising the  − 147 to  + 58 region of the hrpL promoter: 
relative to the transcription start-site,  + 1) was incubated with 0.8 µM of either 
HrpR, HrpS or co-expressed HrpRS and, where indicated, HrpV and/or IHF at the 
specified concentrations (see figure legends). All reactions were incubated at RT for 
15 min and protein–DNA complexes resolved by 4.5% native-PAGE. The gels were 
dried and complexes visualized and quantified using a Fuji FLA-5000 PhosphorIm-
ager (Fuji).
ATP binding and hydrolysis assays. ATP binding was carried out in 20 µl total reac-
tion volume containing 10 µM of purified protein in reaction buffer (20 mM Tris pH 
8.0, 50 mM NaCl, 0.1 mM EDTA and 5% glycerol)) supplemented with 40 µCi [α-32P] 
ATP (3,000 Ci mmol − 1). Sample drops were spotted onto a 4 °C cooled glass plate and 
exposed to ultraviolet light, illuminating (254 nm, UVG-54, UVP) for 15 min on ice. 
Reactions were stopped by adding 10 µl formic acid and proteins resolved by 12% 
SDS–PAGE analysis. Gels were stained by Sypro-ruby fluorescent protein stain  
(Invitrogen) and protein band intensities visualized and quantified on Fuji FLA-5000 
as instructed by the supplier (Bio-Rad). Then gels were dried and radioactivity visual-
ised and quantified by phospho-imaging (Fuji FLA-5000 with Tina 2.10g software).
ATPase assays were conducted in ATPase reaction buffer (20 mM Tris pH 
8.0, 50 mM NaCl, 0.1 mM EDTA and 5% glycerol), incubated for 1 h at 22 °C with 
100 µM ATP containing 0.06 µCi µl − 1 [α-32P] ATP. Proteins were at a final concen-
tration of 10 µM. Reactions were stopped by adding 5 volumes of 2 M formic acid. 
Released [α-32P] ADP was separated from ATP by thin layer chromatography and 
radiolabelled [α-32P]-ADP and [α-32P]-ATP quantified by phospho-imaging (Fuji 
FLA-5000). ATPase assays were also performed in the nifH buffer system (which 
permits HrpV-dependent inhibition of HrpRS transcription activation activity), 
omitting the dATP and substituting this for 100 µM ATP—illustrating that the 
inability of HrpV to repress HrpRS ATPase activity is not simply due to unfavour-
able buffer conditions39.
Gel-filtration assays. Gel-filtration chromatography was carried out at RT in run-
ning buffer (20 mM Tris pH 8.0, 50 mM NaCl, 15 mM MgCl2, 0.02% (w/v) azide) at 
a 0.7 ml min − 1 flow rate using a BioCad Sprint HPLC system and a Bio-Sep-S 3000 
column (Phenomenex), as described previously58. The column was calibrated using 
MW standards (Sigma): Blue Dextran (200 kDa), Thyroglobulin (669 kDa), Ferritin 
(440 kDa), Catalase (232 kDa), Aldolase (158 kDa), Albumin (67 kDa), Ovalbumin 
(43 kDa), Chymotrypsin (25 kDa) and Ribonuclease (13.5 kDa). Fractions were 
analysed by SDS–PAGE using SYPRO ruby stain (Invitrogen) and quantified using 
a Fuji FLA-5000 fluorescence reader. 
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